Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy.

MLA

Truelsen, Christina Glismand, et al. “Circulating Cell-Free DNA as Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiotherapy.” Clinical and Translational Radiation Oncology, vol. 36, June 2022, pp. 9–15. EBSCOhost, https://doi.org/10.1016/j.ctro.2022.06.002.

APA

Truelsen, C. G., Kronborg, C. S., Sørensen, B. S., Callesen, L. B., & Spindler, K.-L. G. (2022). Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy. Clinical and Translational Radiation Oncology, 36, 9–15. https://doi.org/10.1016/j.ctro.2022.06.002

Chicago

Truelsen, Christina Glismand, Camilla Skovhus Kronborg, Brita Singers Sørensen, Louise Bach Callesen, and Karen-Lise Garm Spindler. 2022. “Circulating Cell-Free DNA as Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiotherapy.” Clinical and Translational Radiation Oncology 36 (June): 9–15. doi:10.1016/j.ctro.2022.06.002.